Literature DB >> 6433612

A new clonal strain of rat pituitary tumour cells: a model for non-regulated secretion of prolactin.

M J Reymond, D D Nansel, G H Burrows, W B Neaves, J C Porter.   

Abstract

A new clonal strain of Prl-secreting cells derived from the transplantable rat pituitary tumour, 7315a, has been established in culture. The cells of this strain, designed 235-1, have a highly developed Golgi complex, an extensive rough endoplasmic reticulum, and a few small but no large dense-core granules. When inoculated into athymic mice and rats of the Buffalo strain, the 235-1 cells produce tumours, and the host animals have hypertrophied mammary glands that produce milk, indicating that Prl secreted by these cells has mammotrophic activity. In monolayer culture, the doubling time of 235-1 cells is 31 +/- 1 h (mean +/- SE). The cells secrete Prl, a trace quantity of GH, but no LH, FSH, TSH, ACTH, or alpha-MSH. Prl is released at a rate of 257 +/- 12 fg per h per cell. The cellular content of Prl is 424 +/- 23 fg per cell. Prl secretion by 235-1 cells is not affected by dopaminergic agonists and antagonists, TRH, or oestradiol-17 beta but is inhibited in the presence of EGTA or monensin, an ionophore that is believed to act at the level of the Golgi complex. The subcellular distribution of Prl in 235-1 cells is different from that in rat pituitary cells. In 235-1 cells, Prl is associated not with a single set of dense particles as it is in pituitary cells but with 2 sets of subcellular particles, of which 1 set cosedimented with particles having lysosomal enzyme activity. These findings suggest that Prl secretion by 235-1 cells involves secretory pathways that are different from those seen in normal lactotrophs.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6433612     DOI: 10.1530/acta.0.1060459

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  8 in total

1.  Establishment of a protocol to extend the lifespan of human hormone-secreting pituitary adenoma cells.

Authors:  Aurora Aiello; Maria Francesca Cassarino; Simona Nanni; Antonella Sesta; Francesco Ferraú; Claudio Grassi; Marco Losa; Francesco Trimarchi; Alfredo Pontecorvi; Salvatore Cannavò; Francesca Pecori Giraldi; Antonella Farsetti
Journal:  Endocrine       Date:  2017-04-26       Impact factor: 3.633

Review 2.  Common tools for pituitary adenomas research: cell lines and primary cells.

Authors:  Ziyan Zhu; Weiwei Cui; Dimin Zhu; Nailin Gao; Yonghong Zhu
Journal:  Pituitary       Date:  2020-04       Impact factor: 4.107

Review 3.  Gene therapy for pituitary tumors.

Authors:  Adriana Seilicovich; Daniel Pisera; Sandra A Sciascia; Marianela Candolfi; Mariana Puntel; Weidong Xiong; Gabriela Jaita; Maria G Castro
Journal:  Curr Gene Ther       Date:  2005-12       Impact factor: 4.391

4.  In vivo genomic footprinting of thyroid hormone-responsive genes in pituitary tumor cell lines.

Authors:  S W Kim; I M Ahn; P R Larsen
Journal:  Mol Cell Biol       Date:  1996-08       Impact factor: 4.272

5.  DNase I-hypersensitive sites in the chromatin of rat growth hormone gene locus and enhancer activity of regions with these sites.

Authors:  A Aizawa; T Yoneyama; K Kazahari; M Ono
Journal:  Nucleic Acids Res       Date:  1995-06-25       Impact factor: 16.971

6.  Somatotroph- and lactotroph-specific interactions with the homeobox protein binding sites in the rat growth hormone gene promoter.

Authors:  F Schaufele; B L West; T Reudelhuber
Journal:  Nucleic Acids Res       Date:  1990-09-11       Impact factor: 16.971

7.  Generation of immortal cell lines from the adult pituitary: role of cAMP on differentiation of SOX2-expressing progenitor cells to mature gonadotropes.

Authors:  Ginah L Kim; Xiaomei Wang; Jennifer A Chalmers; David R Thompson; Sandeep S Dhillon; Margaret M Koletar; Denise D Belsham
Journal:  PLoS One       Date:  2011-11-21       Impact factor: 3.240

8.  H19-Dependent Transcriptional Regulation of β3 and β4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer.

Authors:  Lorenza Bacci; Aurora Aiello; Cristian Ripoli; Rossella Loria; Dario Pugliese; Francesco Pierconti; Dante Rotili; Lidia Strigari; Francesco Pinto; Pier Francesco Bassi; Antonello Mai; Claudio Grassi; Alfredo Pontecorvi; Rita Falcioni; Antonella Farsetti; Simona Nanni
Journal:  Int J Mol Sci       Date:  2019-08-17       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.